Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Generational Equity Advises LGM Pharma in its Sale to New Harbor Capital

Generational Equity
Posted on: 06 Dec 17
Generational Equity Advises LGM Pharma in its Sale to New Harbor Capital

PR Newswire

DALLAS, Dec. 6, 2017

DALLAS, Dec. 6, 2017 /PRNewswire/ -- Generational Equity, a leading mergers and acquisitions advisor for privately held businesses, is pleased to announce a majority acquisition of its client, LGM Pharma, by New Harbor Capital LLC. The transaction closed November 15, 2017.

LGM specializes in streamlining the API supply chain throughout all development stages while providing complete technical capabilities and expert regulatory support for a wide range of products. The company serves many active customers across biotech, generic pharma, contract manufacturing, specialty pharma, CDMOs, academic institutes, compounding and pharmaceutical manufacturing industries, supporting all stages of drug development and commercialization by supplying a wide range of APIs and by providing other value-added services.

Generational Equity Managing Director Julie Sandoval's team, led by trusted affiliate Mike LoConte with support from Generational Equity VP Rebecca Gruman, successfully closed the deal.

About LGM Pharma
LGM Pharma is an innovation-driven API company, involved in distribution of quality cGMP pharma ingredients to leading pharmaceutical companies. LGM specializes in providing integrated sourcing options, complete technical capabilities and regulatory documentation support for a wide range of APIs.

For more information, visit https://www.lgmpharma.com/.

About New Harbor Capital
New Harbor Capital is a Chicago-based private equity firm with over $400 million of capital under management, focused on investing in lower middle market, growth-oriented healthcare, education and business services companies. Our Partners have been private equity investors for over 20 years, partnering with strong management teams to systematically enable accelerated growth in value creation. Since 2000, the New Harbor team has completed over 200 investments. As an experienced strategic partner, New Harbor supports management with ideas, connections and resources to capitalize on growth potential.

For more information, visit http://www.newharborcapital.com/

About Generational Equity
Generational Equity, DealForce, and Generational Capital Markets, member FINRA/SIPC, are part of the Generational Group, which is headquartered in Dallas and is one of the leading M&A advisory firms in North America. With over 200 professionals located throughout North America, the companies help business owners release the wealth of their business by providing merger, acquisition and strategic growth advisory services. Their four-step approach features exit planning education, business valuation, value enhancement strategies, and M&A transactional services.

The M&A Advisor named the company the 2016 and 2017 Investment Banking Firm of the Year. For more, visit http://www.genequityco.com/ or the Generational Equity press room.

For more information:
Carl Doerksen
972-232-1125
cdoerksen@generational.com

 

View original content with multimedia:http://www.prnewswire.com/news-releases/generational-equity-advises-lgm-pharma-in-its-sale-to-new-harbor-capital-300565386.html

SOURCE Generational Equity

PR Newswire
www.prnewswire.com

Last updated on: 06/12/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.